From the clinic to the lab, understanding medulloblastoma relies on molecular profiling

Hypnotic suggestions can make a complex task easy by helping vision fill in the blanks
27 January 2021
Support for self isolation must be a top priority, say experts
27 January 2021

From the clinic to the lab, understanding medulloblastoma relies on molecular profiling

Scientists at St. Jude Children’s Research Hospital and their colleagues have published a detailed account of SJMB03, a clinical trial for pediatric patients with medulloblastoma. Additionally, they report results of the largest analysis of matched primary and relapsed medulloblastoma tumors to date. In both the clinic and the lab, results underscore the need for integrated molecular assessment of these tumors. The papers were published recently in the Journal of Clinical Oncology.

Comments are closed.